Conducting radiogenomic research--do not forget careful consideration of the clinical data.
about
Radiogenomics: radiobiology enters the era of big data and team science.Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.The current progress and future prospects of personalized radiogenomic cancer study.Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis.The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy.Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Radiogenomics: the search for genetic predictors of radiotherapy response.Radiogenomics and radiotherapy response modeling.Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma.A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab.
P2860
Q30833608-6481414E-1283-4BA4-89A8-268DF1A7BE01Q31116483-9E06FFCF-0505-4858-9BF5-8DFC8261FFB7Q33598555-2AD20FAD-45AE-4908-9425-B9236DAC4FFEQ35083627-2547223B-9661-41BE-9C0E-7F7AE90F8125Q35668905-FC727504-11FE-4FBC-9B0C-6903554F3E7BQ36077772-74B4C906-FC03-441E-AD4A-80C6753E5E75Q36238280-90343BFC-F550-43C3-934E-14A3BA704442Q36898448-B8926907-89E0-4C62-B1CA-73D582D79105Q37624254-805DAD6B-D227-4E00-89D2-933D2481E4E4Q38294605-656AFB91-9D85-4AE3-93F7-83D5E93B2D24Q38665620-0390BD23-DCB9-40BA-B699-897A91AC03C7Q40007526-5C9DE524-C735-446E-910F-F0A6F0327E99Q42208433-CF0653A1-D6E8-4073-905F-1BFCCCC4D0E5Q50491249-7442F297-7E95-451A-9934-8FEA81D3F302Q50559529-DE1B9934-1A65-4389-84CE-4FB9DBAFB01F
P2860
Conducting radiogenomic research--do not forget careful consideration of the clinical data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Conducting radiogenomic resear ...... deration of the clinical data.
@ast
Conducting radiogenomic resear ...... deration of the clinical data.
@en
type
label
Conducting radiogenomic resear ...... deration of the clinical data.
@ast
Conducting radiogenomic resear ...... deration of the clinical data.
@en
prefLabel
Conducting radiogenomic resear ...... deration of the clinical data.
@ast
Conducting radiogenomic resear ...... deration of the clinical data.
@en
P2093
P50
P1476
Conducting radiogenomic resear ...... deration of the clinical data.
@en
P2093
Clare Griffin
Gillian C Barnett
Johannes A Langendijk
John R Yarnold
Mechtild Krause
Philip Poortmans
P304
P356
10.1016/J.RADONC.2012.11.004
P577
2012-12-01T00:00:00Z